loader
Please Wait
Applying Filters...

AbbVie Header AbbVie Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Miocamycin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Miocamycin

    DOSSIERs // Finished Dosage Forms

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass

    Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

    Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    2D Structure
    1. Also known as: Miocamycin, Acecamycin, Miokamycin, Ponsinomycin, 3'',9-diacetylmydecamycin, 55881-07-7
    Molecular Formula
    C45H71NO17
    Molecular Weight
    898.0  g/mol
    InChI Key
    GQNZGCARKRHPOH-RQIKCTSVSA-N
    FDA UNII
    3T48CPS7U2
    Miocamycin is a macrolide type antimicrobial. This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia. It has shown to be effective against several gram-positive and gram-negative microbes and may be useful in the treatment of upper and lower respiratory tract infections, and urogenital tract infections or as an alternative to erythromycin treatment.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-acetyloxy-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4-acetyloxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] propanoate
    2.1.2 InChI
    InChI=1S/C45H71NO17/c1-13-34(50)59-33-23-36(52)55-26(4)18-16-15-17-19-32(58-29(7)48)25(3)22-31(20-21-47)41(42(33)54-12)62-44-39(53)38(46(10)11)40(27(5)57-44)61-37-24-45(9,63-30(8)49)43(28(6)56-37)60-35(51)14-2/h15-17,19,21,25-28,31-33,37-44,53H,13-14,18,20,22-24H2,1-12H3/b16-15+,19-17+/t25-,26-,27-,28+,31+,32+,33-,37+,38-,39-,40-,41+,42+,43+,44+,45-/m1/s1
    2.1.3 InChI Key
    GQNZGCARKRHPOH-RQIKCTSVSA-N
    2.1.4 Canonical SMILES
    CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)OC(=O)C)N(C)C)O)CC=O)C)OC(=O)C)C
    2.1.5 Isomeric SMILES
    CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)OC(=O)C)N(C)C)O)CC=O)C)OC(=O)C)C
    2.2 Other Identifiers
    2.2.1 UNII
    3T48CPS7U2
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Maidimeisu

    2. Midecamin

    3. Midecamycin

    4. Midecamycin Diacetate

    5. Midekamycin

    6. Midekamycin Acetate

    7. Mosil

    8. Mydecamycin

    9. Myoxam

    10. Neoisomidecamycin

    11. Normicina

    12. Sf 837

    13. Sf-837

    2.3.2 Depositor-Supplied Synonyms

    1. Miocamycin

    2. Acecamycin

    3. Miokamycin

    4. Ponsinomycin

    5. 3'',9-diacetylmydecamycin

    6. 55881-07-7

    7. Midecamycin Acetate [jan]

    8. Midecamycin Diacetate

    9. 9,3''-di-o-acetylmidecamycin

    10. Leucomycin V, 3b,9-diacetate 3,4b-dipropanoate

    11. 3t48cps7u2

    12. Mom

    13. [(4r,5s,6s,7r,9r,10r,11e,13e,16r)-10-acetyloxy-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4-acetyloxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] Propanoate

    14. 9,3''-diacetylmidecamycin

    15. Einecs 259-879-6

    16. Unii-3t48cps7u2

    17. Macroral

    18. Miocamen

    19. Mosil

    20. Miocamycin (tn)

    21. Miocamycin [mi]

    22. Midecamycin Acetate (jp17)

    23. Schembl139293

    24. Chembl1091024

    25. Dtxsid60905087

    26. Leucomycin V, 3(sup B),9-diacetate 3,4(sup B)-dipropanoate

    27. Midecamycin Acetate [who-dd]

    28. Zinc169677000

    29. 1532-rb

    30. Leucomycinv,3b,9-diacetate3,4b-dipropanoate

    31. D01636

    32. Q3858659

    33. W-105540

    34. Midecamycin Acetate, Antibiotic For Culture Media Use Only

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 898.0 g/mol
    Molecular Formula C45H71NO17
    XLogP33.8
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count18
    Rotatable Bond Count18
    Exact Mass897.47219980 g/mol
    Monoisotopic Mass897.47219980 g/mol
    Topological Polar Surface Area218 Ų
    Heavy Atom Count63
    Formal Charge0
    Complexity1590
    Isotope Atom Count0
    Defined Atom Stereocenter Count16
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count2
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Bacterial Agents

    Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

    4.2 ATC Code

    J - Antiinfectives for systemic use

    J01 - Antibacterials for systemic use

    J01F - Macrolides, lincosamides and streptogramins

    J01FA - Macrolides

    J01FA11 - Miocamycin

    Post Enquiry
    POST ENQUIRY